FLOSSBACH VON STORCH SE
•CIK: 1575677•Filing: Q4 2025
Flossbach von Storch AG, managed by the seasoned duo of Dr. Andreas Flossbach and Dr. Thorsten von Storch, maintains a concentrated portfolio with a focus on high-quality, dividend-paying stocks, currently holding 111 positions with a $25.2 billion AUM. Recently, the fund has notably increased its positions in Vertex Pharmaceuticals and Starbucks by 296% and 136%, respectively, while significantly reducing stakes in Mondelez and Alibaba by 74% and 65%, reflecting a strategic shift towards growth-oriented and resilient sectors.
Total AUM
$25.2B
+ $3.0M in options
QoQ Performance
-0.6%
Positions
102
+ 1 option
Top 10 Concentration
48.6%
Latest Filing
Q4 2025
Top Holdings Allocation
GOOGL
MSFT
AMZN
BRK/B
TMO
GOOGL7.4%
MSFT6.0%
AMZN6.0%
BRK/B5.5%
TMO5.0%
SCHW4.1%
APH3.9%
DHR3.7%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other32.0%
Technology22.5%
Financial14.6%
Healthcare13.5%
Consumer10.4%
Consumer Staples3.7%
Materials2.3%
Industrial0.5%
🚪 Exited Positionssold since Q3 2025
—
SMURFIT WESTROCK
SOLD
$8.6M
+4 more exited positions
Changes from Q3 2025
NEW3 new positions
↑40 increased
↓52 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023